Literature DB >> 22477360

Functional outcomes in schizophrenia: employment status as a metric of treatment outcome.

Rebecca Schennach1, Richard Musil, Hans-Jürgen Möller, Michael Riedel.   

Abstract

The importance of an adequate and satisfying level of functioning for the course and outcome of schizophrenia has been increasingly emphasized by researchers in recent years. Employment status is a major component of the patient's functioning and is generally believed to be essential for well-being, satisfaction in life, and a better prognosis for schizophrenia illness. This article summarizes recent relevant publications concerning the employment status of schizophrenia patients and its influence on treatment outcome. Given the significant link between employment status and outcome in schizophrenia, different influencing factors of employment are discussed, as they mirror potential treatment targets. Finally, currently available treatment strategies for the improvement of employment status are outlined.

Entities:  

Mesh:

Year:  2012        PMID: 22477360     DOI: 10.1007/s11920-012-0261-3

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  56 in total

1.  Response to vocational rehabilitation during treatment with first- or second-generation antipsychotics.

Authors:  Gary R Bond; Hea-Won Kim; Piper S Meyer; P Joseph Gibson; Sandra Tunis; Jovier D Evans; Paul Lysaker; Marion L McCoy; Jerry Dincin; Haiyi Xie
Journal:  Psychiatr Serv       Date:  2004-01       Impact factor: 3.084

Review 2.  Review on vocational predictors: a systematic review of predictors of vocational outcomes among individuals with schizophrenia: an update since 1998.

Authors:  Hector W H Tsang; Ada Y Leung; Raymond C K Chung; Morris Bell; Wai-Ming Cheung
Journal:  Aust N Z J Psychiatry       Date:  2010-06       Impact factor: 5.744

Review 3.  World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.

Authors:  Peter Falkai; Thomas Wobrock; Jeffrey Lieberman; Birte Glenthoj; Wagner F Gattaz; Hans-Jürgen Möller
Journal:  World J Biol Psychiatry       Date:  2005       Impact factor: 4.132

4.  Recovery from schizophrenia: a concept in search of research.

Authors:  Robert Paul Liberman; Alex Kopelowicz
Journal:  Psychiatr Serv       Date:  2005-06       Impact factor: 3.084

5.  Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept?

Authors:  Philip D Harvey; Alan S Bellack
Journal:  Schizophr Bull       Date:  2009-01-06       Impact factor: 9.306

6.  Neurocognition and occupational functioning in patients with first-episode psychosis: a 2-year follow-up study.

Authors:  Marte Tandberg; Torill Ueland; Kjetil Sundet; Ulrik Haahr; Inge Joa; Jan Olav Johannessen; Tor Ketil Larsen; Stein Opjordsmoen; Bjørn Rishovd Rund; Jan Ivar Røssberg; Erik Simonsen; Per Vaglum; Ingrid Melle; Svein Friis; Thomas McGlashan
Journal:  Psychiatry Res       Date:  2011-05-14       Impact factor: 3.222

7.  Predictors of relapse in the year after hospital discharge among patients with schizophrenia.

Authors:  Rebecca Schennach; Michael Obermeier; Sebastian Meyer; Markus Jäger; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Florian Seemüller; Hans-Jürgen Möller; Michael Riedel
Journal:  Psychiatr Serv       Date:  2012-01       Impact factor: 3.084

Review 8.  What do we know about neuropsychological aspects of schizophrenia?

Authors:  Barton W Palmer; Sharron E Dawes; Robert K Heaton
Journal:  Neuropsychol Rev       Date:  2009-07-30       Impact factor: 7.444

9.  Sociodemographic and clinical factors associated with relapse in schizophrenia.

Authors:  Gobind Chabungbam; Ajit Avasthi; Pratap Sharan
Journal:  Psychiatry Clin Neurosci       Date:  2007-12       Impact factor: 5.188

Review 10.  Thinking about the future cognitive remediation therapy--what works and could we do better?

Authors:  Til Wykes; Will D Spaulding
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

View more
  10 in total

1.  Antipsychotic Treatment Experiences of People with Schizophrenia: Patient Perspectives from an Online Survey.

Authors:  Michael J Doane; Martha Sajatovic; Peter J Weiden; Amy K O'Sullivan; Stephen Maher; Jakob B Bjorner; Asia Sikora Kessler; Julia Carpenter-Conlin; Leona Bessonova; Dawn I Velligan
Journal:  Patient Prefer Adherence       Date:  2020-10-28       Impact factor: 2.711

2.  Atypical Treatment Switches in Schizophrenia Patients: Drivers and Associated Outcomes.

Authors:  Rezaul Khandker; Jason Shepherd; Farid Chekani; Zaina Qureshi; Hollie Bailey; Mia Berry; Jack Wright; Lucy Massey
Journal:  Neuropsychiatr Dis Treat       Date:  2022-05-18       Impact factor: 2.989

3.  Occupational functioning, symptoms and neurocognition in patients with psychotic disorders: investigating subgroups based on social security status.

Authors:  Marte Tandberg; Kjetil Sundet; Ole A Andreassen; Ingrid Melle; Torill Ueland
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-10-13       Impact factor: 4.328

4.  The Effects of Paliperidone Palmitate 1 Month on the Employment Status and Social Functioning of Patients with Schizophrenia.

Authors:  Takashi Ohnishi; Hisanori Kobayashi; Toshio Yamaoka; Tokiko Toma; Keiko Imai; Akihide Wakamatsu; Kenichi Noguchi
Journal:  Innov Clin Neurosci       Date:  2020-01-01

5.  The revolving door phenomenon revisited: time to readmission in 17’145 [corrected] patients with 37'697 hospitalisations at a German psychiatric hospital.

Authors:  Ulrich Frick; Hannah Frick; Berthold Langguth; Michael Landgrebe; Bettina Hübner-Liebermann; Göran Hajak
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

6.  Validation of the German Version of the Social Functioning Scale (SFS) for schizophrenia.

Authors:  Jona R Iffland; Denise Lockhofen; Harald Gruppe; Bernd Gallhofer; Gebhard Sammer; Bernd Hanewald
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

7.  Predictors of vocational status in schizophrenia patients--Results from the Polish nationwide survey.

Authors:  Andrzej Kiejna; Patryk Piotrowski; Błażej Misiak; Tomasz Adamowski; Agata Schubert; Iwona Skrzekowska-Baran; Dorota Frydecka
Journal:  Int J Soc Psychiatry       Date:  2015-04-02

8.  Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia.

Authors:  George Awad; Daisy Ng-Mak; Krithika Rajagopalan; Jay Hsu; Andrei Pikalov; Antony Loebel
Journal:  BMC Psychiatry       Date:  2016-06-01       Impact factor: 3.630

9.  Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate.

Authors:  Steven G Potkin; Jean-Yves Loze; Carlos Forray; Ross A Baker; Christophe Sapin; Timothy Peters-Strickland; Maud Beillat; Anna-Greta Nylander; Peter Hertel; Simon Nitschky Schmidt; Anna Eramo; Karina Hansen; Dieter Naber
Journal:  Int J Neuropsychopharmacol       Date:  2017-01-01       Impact factor: 5.176

10.  The Factors Affecting the Relationship between Remission Status and Employment in Chronic Schizophrenia Patients.

Authors:  Burcu Rahşan Erim; Hamid Boztaş; Mustafa Yıldız; Ersin Uygun
Journal:  Psychiatry Investig       Date:  2019-11-06       Impact factor: 2.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.